Inflammation is a key factor in the pathogenesis of CKD, and, at the molecular level, TGF-β is known to be a key factor in the kidney fibrosis pathway, including inflammatory reactions [28,29,30]. This evidence concerns the gene TGFB1 and chronic kidney disease.